A device to track light exposure for improving sleep in Alzheimer's patients
A light exposure tracker designed to improve the circadian entrainment for Alzheimer Disease patients
['FUNDING_SBIR_2'] · BLUE IRIS LABS, INC. · NIH-10707191
This study is testing a new device that tracks light exposure to help improve sleep and alertness for people with Alzheimer's disease, making it easier for them to feel better and think more clearly during the day.
Quick facts
| Phase | ['FUNDING_SBIR_2'] |
|---|---|
| Study type | Nih_funding |
| Sex | All |
| Sponsor | BLUE IRIS LABS, INC. (nih funded) |
| Locations | 1 site (FAIRFAX, UNITED STATES) |
| Trial ID | NIH-10707191 on ClinicalTrials.gov |
What this research studies
This research focuses on developing a light exposure tracker aimed at enhancing circadian rhythms and sleep quality in patients with Alzheimer's disease. By monitoring light exposure patterns, the device seeks to optimize the timing and intensity of light to improve sleep efficiency and daytime alertness. The approach is based on the understanding that proper light exposure can significantly benefit cognitive function and overall well-being in older adults. Participants will use this device to gather data on their light exposure, which can then be analyzed to tailor interventions that promote better sleep.
Who could benefit from this research
Good fit: Ideal candidates for this research are older adults diagnosed with Alzheimer's disease or related dementias who experience sleep disturbances.
Not a fit: Patients who do not have Alzheimer's disease or related dementias may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to improved sleep quality and cognitive function for Alzheimer's patients, enhancing their quality of life.
How similar studies have performed: Previous research has shown promising results with light therapy in improving sleep and cognitive function in older adults, indicating that this approach has potential for success.
Where this research is happening
FAIRFAX, UNITED STATES
- BLUE IRIS LABS, INC. — FAIRFAX, UNITED STATES (ACTIVE)
Researchers
- Principal investigator: PAGE, ERIK — BLUE IRIS LABS, INC.
- Study coordinator: PAGE, ERIK
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.
Conditions: Alzheimer disease dementia, Alzheimer syndrome